Quality of Life Study With Adalimumab in Rheumatoid Arthritis
NCT00234936 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2007-10-03
Summary
The purpose of the study is to evaluate the ability of adalimumab combined with methotrexate to improve the quality of life in patients with active RA.
Conditions
Interventions
- DRUG
- DRUG
-
Methotrexate
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Medical Information · Abbott
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-12-31
More Related Trials
-
Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
NCT00420927 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
NCT01225393 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis
NCT00195663 ·Status: COMPLETED ·Phase: PHASE3
-
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00235859 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice
NCT01736189 ·Status: COMPLETED
-
A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis
NCT00448383 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Observational Study in Subjects With Rheumatoid Arthritis
NCT00234884 ·Status: COMPLETED
-
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
NCT01960855 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease
NCT01893996 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
NCT02141997 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
NCT03823391 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
NCT00646386 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
NCT00649545 ·Status: APPROVED_FOR_MARKETING
-
A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis
NCT00233571 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00048568 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT02097264 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00647920 ·Status: COMPLETED ·Phase: PHASE3
-
Rheumatoid Arthritis Satisfaction Outcome Research
NCT03703817 ·Status: COMPLETED
-
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
NCT06016517 ·Status: NOT_YET_RECRUITING
-
Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
NCT00650026 ·Status: APPROVED_FOR_MARKETING
-
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
NCT00122382 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission
NCT00808509 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Patients With Rheumatoid Arthritis
NCT00966875 ·Status: COMPLETED ·Phase: PHASE2
-
Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)
NCT01346488 ·Status: COMPLETED
-
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
NCT05814627 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3